Sign up to save your podcasts
Or
Share Does 'Fantastic' CRC Response Herald a New Era?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Does 'Fantastic' CRC Response Herald a New Era?
Dr. David Kerr reports on a provocative phase 2 trial in quadruple wild-type colorectal cancer and surmises that CRC may be catching up with lung cancer as a disease increasingly defined by genotype.
View all episodes
By MedscapeDr. David Kerr reports on a provocative phase 2 trial in quadruple wild-type colorectal cancer and surmises that CRC may be catching up with lung cancer as a disease increasingly defined by genotype.